Related Experiment Videos
Pathogenesis of structural vascular changes in hypertension.
1Department of Medicine, VA Medical Center and University of Minnesota Medical School, Minneapolis, Minnesota 55417, USA. simo0038@tc.umn.edu
Journal of Hypertension
|April 27, 2004
Summary
Angiotensin II (ANG II) is the primary driver of structural vascular changes (SVCs) in hypertension, meeting all criteria for predictability, reversibility, and reproducibility. Other factors like salt and aldosterone play lesser roles in SVC development.
Area of Science:
- Cardiovascular Research
- Nephrology
- Hypertension Pathophysiology
Background:
- Structural vascular changes (SVCs) are key in hypertension development.
- The roles of angiotensin II (ANG II), sodium chloride, sympathetic activation, obesity, and aldosterone in SVCs are debated.
Purpose of the Study:
- To evaluate the pathogenic roles of ANG II, sodium chloride, sympathetic activation, obesity, and aldosterone in hypertension-related SVCs.
- To assess these factors based on predictability, reversibility, and reproducibility of SVCs.
Main Methods:
- Review of existing literature and experimental data.
- Analysis of factors based on three criteria: predictability, reversibility, and reproducibility of SVCs.
Main Results:
- Only ANG II met all three criteria for inducing SVCs.
- ANG II increases preglomerular vascular resistance via structural changes in renal arteries.
- High salt intake and aldosterone showed limited or differing roles in SVCs; sympathetic activation evidence was inconclusive; obesity was not directly linked to SVCs.
Conclusions:
- Structural changes in renal cortical arteries, driven by ANG II, are crucial for hypertension.
- Progressive trophic stimulation of preglomerular resistance vessels by ANG II is a primary cause of hypertension.